- SEK4.10bn
- SEK3.93bn
- -SEK414.00m
Brief: Linc Q3 EBIT At SEK 107.7 Mln
Brief: Linc Reports 6.1% Return On NAV In Q2
Brief: Linc: Net Asset Value SEK 4,254 Million As Of March 31
Brief: Linc CEO Buys SEK 1.3 Million Of Shares
Brief: Linc Q4 Return On NAV At -2.4%
Brief: Linc CEO Buys SEK 676,500 Worth Of Co Shares
Brief: Linc CEO Buys Shares In Co Worth SEK 703,500
Brief: Linc Q3 Operating Profit SEK 351.0 Million
Brief: Linc Q2 Operating Profit At SEK 364.8 Million
Brief: Linc Q1 NAV SEK 3.84 Bln
Brief: Linc Q4 Operating Profit Down At SEK 202.8 Mln
Brief: Linc End-Sept NAV Sek 4,620 Million
Brief: Linc Net Asset Value At SEK 4,631 Million As Of June 30
Brief: Japan's Asahi Kasei Corp: To Acquire Sweden's Calliditas Therapeutics AB For Total Equity Value Of About SEK 11.8 Billion (About JPY 174 Billion)
Brief: Linc Q1 Earnings Per Share Turn To Profit Of SEK 1.1
Brief: Linc Reaches 50% Ownership In ACE Health After Investment
Brief: Linc Q4 Net Asset Value Up At To Sek 3.5 Mln
Brief: Linc Chairman Bengt Julander Sells 200 000 Shares - Finansinspektionen
Brief: Linc Net Asset Value At SEK 3,038 Mln As Of Sept 30